GenFleet Therapeutics (Shanghai) Inc. (02595) submitted a monthly return as of 31 January 2026, confirming that the total issued share capital remains composed of 338,029,020 H shares and 32,337,610 unlisted shares, each with a par value of RMB0.1. The sum of these shares corresponds to a total issued share capital of RMB 37,036,663, showing no increase or decrease over the prior month.

The filing also confirms that the public float requirement for the H shares, set at 19.86% of the total issued shares (excluding any treasury shares), has been duly complied with. There were no share options, warrants, convertibles, or other share issuance arrangements reported for the period, and no treasury shares were held.